Pharmacological profile and efficacy
In clinical practice, indomethacin is deservedly considered one of the most powerful anti-inflammatory drugs among all existing NSAIDs (nonsteroidal anti-inflammatory drugs). Its pharmacological activity is aimed at rapid and effective suppression of inflammatory processes. An important distinctive feature of the drug is the rapid development of the antipyretic effect. Unlike some other agents that lower temperature gradually, indomethacin is capable of relieving fever in the shortest possible time. When analyzing pharmacological properties, it is important to clearly differentiate this feature: the drug is characterized precisely by a rapid, rather than slow, development of the antipyretic action.
Expanded mechanism of action
The mechanism of action of indomethacin is significantly broader than that of most standard NSAIDs, which explains its outstanding clinical efficacy. The pharmacodynamics of the drug is based on three fundamental processes:
- Reversible inhibition of COX (cyclooxygenase). This is the classical pathway: the drug temporarily binds to the enzyme, interrupting arachidonic acid metabolism and halting the synthesis of inflammatory mediators.
- Inhibition of phospholipase A and C. This is a unique feature of the expanded mechanism. By blocking these enzymes, the drug acts at additional stages of the inflammatory cascade.
- Inhibition of neutrophil proliferation. Neutrophils actively participate in sustaining inflammation. Indomethacin suppresses their proliferation, thereby depriving the pathological process of cellular support.
Main clinical indications
Due to its high potency and associated risks, indomethacin is prescribed for severe, chronic, or acute systemic pathologies of the musculoskeletal system. The main indications include:
- Ankylosing spondylitis (Bechterew's disease) — systemic inflammation of the spinal joints requiring potent suppression of inflammation.
- Gout — the drug is effectively used to relieve acute attacks of gouty arthritis.
- Various rheumatic diseases — a wide range of inflammatory lesions requiring aggressive therapy.
Safety profile and adverse effects
The use of indomethacin is strictly limited by its toxicity. The drug possesses all the typical adverse effects characteristic of the NSAID class, but its main clinical problem lies in specific risks:
- Pronounced ulcerogenic effect: the drug acts aggressively on the mucous membrane, provoking rapid ulcer formation in the gastrointestinal tract.
- Hematological disorders: indomethacin can suppress hematopoiesis, which manifests as anemia and leukopenia.
- Neurotoxicity: a specific negative impact on the central nervous system. Patients frequently experience intense headaches and marked dizziness.
Briefly: answers to topical questions
To which chemical group of derivatives does indomethacin belong?
Indomethacin belongs to the chemical group of acetic acid derivatives, specifically indoleacetic and phenylacetic acids. In its chemical structure, this drug contains a specific indole ring. Other nonsteroidal anti-inflammatory drugs, such as diclofenac and ketorolac, also belong to this same structural group of acetic acid derivatives.
What are the absolute contraindications for indomethacin?
Absolute contraindications for prescribing indomethacin include pathologies of the gastrointestinal tract, blood system, liver, as well as pediatric age.
The drug is strictly contraindicated in:
- peptic ulcer disease of the stomach and duodenum;
- blood clotting disorders and increased bleeding tendency;
- liver dysfunction;
- bronchial asthma and hypersensitivity to aspirin;
- age under 14 years (for the tablet form).
In obstetric practice, the drug is contraindicated in fetal growth restriction and congenital renal malformations in the fetus.
What gastrointestinal side effects does indomethacin cause?
Reported gastrointestinal side effects include:
- pronounced ulcerogenic effect (ulcer formation) and erosive-ulcerative lesions of the stomach;
- gastrointestinal bleeding;
- nausea;
- gastritis;
- reflux esophagitis.
The maximum risk of developing erosive-ulcerative lesions with indomethacin intake shifts to days 7–14 of therapy.
With which drugs does indomethacin enter into clinically significant interactions?
The presented materials indicate that indomethacin suppresses steroid production, thereby reducing the anti-anxiety effect of certain tranquilizers whose action on GABA receptors is associated with the stimulation of endogenous steroid synthesis. An example of such a drug is etifoxine.
In what dosage forms is indomethacin available?
The cited sources indicate oral and rectal administration for indomethacin. Tablets are used orally; rectal administration is indicated for a starting dose of 50–100 mg in tocolytic therapy. The specific rectal dosage form is not named in the sources.
To easily remember the three specific side effects of indomethacin, use the mnemonic HUN: H — Hematological disorders (anemia, leukopenia), U — Ulcerogenic effect (ulcer formation), N — Neurotoxicity (headache and dizziness). Association: the drug is so powerful that it strikes the body like an invasion by the "Huns".
Class and exam questions
How quickly does the antipyretic effect develop after taking indometacin?
Indomethacin is characterized precisely by the rapid development of the antipyretic effect. This is one of its key pharmacodynamic advantages in relieving acute conditions.
What is the extended mechanism of action of this drug?
In addition to standard reversible inhibition of the COX enzyme, indometacin additionally blocks phospholipases A and C, and also directly inhibits neutrophil proliferation.
To which pharmacological group does indometacin belong, and what side effects are typical for it?
Indometacin belongs to the NSAID (non-steroidal anti-inflammatory drug) group. Consequently, it exhibits all the typical side effects associated with this group.
What specific risks are associated with taking indometacin?
Specific risks include a pronounced ulcerogenic effect (ulcer formation), neurotoxicity (severe headache, dizziness), and hematologic disorders (anemia and leukopenia).
What else to study on this topic
- Comparative profile of the anti-inflammatory potency of indometacin versus other NSAIDs.
- The biochemical role of phospholipases A and C in the arachidonic acid cascade.
- Pathogenesis of ulcerogenesis induced by systemic COX inhibition.
- Mechanisms of neurotoxicity associated with indoleacetic acid derivatives.
- Protocols for the use of indometacin in acute gout flares and ankylosing spondylitis.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Indometacin" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Analgesics" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.